When did Exactus' stock split?

Exactus shares reverse split on the morning of Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Exactus own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC) , VIVUS (VVUS) , Akero Therapeutics (AKRO) , CymaBay Therapeutics (CBAY) , Cumberland Pharmaceuticals (CPIX) , Entasis Therapeutics (ETTX) , Evelo Biosciences (EVLO) , Kaleido Biosciences (KLDO) .

How do I buy shares of Exactus?

Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:EXDI

Exactus (EXDI) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free EXDI Stock Alerts

Compare

Today's Range: N/A
50-Day Range: $0.07
▼
$0.07
52-Week Range: N/A

Volume: 257,300 shs
Average Volume: 83,144 shs
Market Capitalization: $38.94 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Exactus alerts:

Ad Crypto 101 Media

SHOCKING Crypto Leak…

A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.

Claim your free seat by clicking here now.

About Exactus Stock (OTCMKTS:EXDI)

Exactus, Inc., is a farmer and manufacturer of hemp-derived phytocannabinoid products. The company sells its CBD products through its Green Goddess brand and third-party resellers. Exactus is engaged in producing industrial hemp from farms in Oregon and plans to extract and manufacture directly through cGMP facilities. Industrial hemp is a type of cannabis, defined by the federal government as having THC (tetrahydrocannabinol) content of 0.3 percent or less. THC is the psychoactive compound found in cannabis.

Ad Crypto 101 Media

SHOCKING Crypto Leak…

Claim your free seat by clicking here now.

EXDI Stock News Headlines

February 7, 2024 | news.yahoo.com

Clapham chemical attack – live: Suspect Abdul Ezedi was ‘very angry’ after sister was shot dead

June 4, 2023 | investing.com

Starbreeze AB B (STZEb)

April 19, 2024 | Crypto 101 Media (Ad)

SHOCKING Crypto Leak…

October 30, 2021 | finanznachrichten.de

Exactus Inc.: CBD Company Panacea Life Sciences Sees Promise as Denver Airport Reaches Third-Highest Passenger Traffic in World

October 26, 2021 | finance.yahoo.com

Exactus, Inc. to Present at BIO CEO & Investor Conference

October 15, 2021 | finanznachrichten.de

Exactus Inc.: Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State University

October 14, 2021 | finance.yahoo.com

Grand Opening of the Panacea Life Sciences Cannabinoid Research Center at Colorado State University

See More Headlines

Receive EXDI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exactus and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medicinals & Botanicals
Sub-Industry: N/A
Current Symbol: OTCMKTS:EXDI
CUSIP: N/A
CIK: 1552189
Web: www.exactusinc.com
Phone: 804-205-5036
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,460,000.00
Net Margins: N/A
Pretax Margin: -15,131.74%
Return on Equity: -3,272.69%
Return on Assets: -185.29%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.32
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $2.07 million
Price / Sales: 0.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.09) per share
Price / Book: N/A

Miscellaneous

Outstanding Shares: 599,005,000
Free Float: 209,652,000
Market Cap: $38.94 million
Optionable: Not Optionable
Beta: 4.21

(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

Emiliano Aloi
President and Interim CEO
Kenneth E. Puzder
Chief Financial Officer and Director
Andrew Johnson
Chief Strategy Officer
Bobby Yampolsky
Interim Chairman

Key Competitors

View All Competitors

EXDI Stock Analysis - Frequently Asked Questions

When did Exactus' stock split?: Exactus shares reverse split on the morning of Thursday, October 28th 2021. The 1-28 reverse split was announced on Thursday, October 28th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, October 28th 2021. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.
What other stocks do shareholders of Exactus own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Exactus investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), Akero Therapeutics (AKRO), CymaBay Therapeutics (CBAY), Cumberland Pharmaceuticals (CPIX), Entasis Therapeutics (ETTX), Evelo Biosciences (EVLO), Kaleido Biosciences (KLDO).
How do I buy shares of Exactus?: Shares of EXDI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:EXDI) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Exactus (EXDI) Stock Price, News & Analysis

About Exactus Stock (OTCMKTS:EXDI)

EXDI Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

EXDI Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info